@aatisket
I have a different opinion re the Carto 3 mapping system. It will have a material impact but there is no reason to expect it to show in the share price yet. The current share price is not a measure of Carto 3's significance.
Carto 3 is used in a very large number of cardiac clinics in US and Europe. FDA approval for MPC-150-IM to use it greatly expands the number of sites where the product can be used. It should compress the time line. This is very important to investors but is way too early for investors to factor it in.
@aatisket I have a different opinion re the Carto 3 mapping...
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |